Cargando…
The Pathophysiology and Pharmacological Treatment of Huntington Disease
Introduction: Huntington disease (HD) is a progressive neurodegenerative condition characterised by motor, cognitive and behavioural dysfunction, and has an autosomal dominant mode of inheritance. As there is currently no treatment to delay progression of the disease, pharmacological intervention is...
Autores principales: | Pidgeon, Connie, Rickards, Hugh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5214454/ https://www.ncbi.nlm.nih.gov/pubmed/22713409 http://dx.doi.org/10.3233/BEN-2012-120267 |
Ejemplares similares
-
Social cognition and quality of life in Huntington's disease
por: Eddy, Clare M., et al.
Publicado: (2022) -
Purinergic Signaling in the Pathophysiology and Treatment of Huntington’s Disease
por: Wiprich, Melissa Talita, et al.
Publicado: (2021) -
Molecular Pathophysiological Mechanisms in Huntington’s Disease
por: Jurcau, Anamaria
Publicado: (2022) -
The Role of Dopamine and Glutamate Modulation in Huntington Disease
por: Mittal, Sumeer K., et al.
Publicado: (2013) -
What does social cognition look like in everyday social functioning in Huntington’s disease? A protocol for a scoping review to explore and synthesise knowledge about social cognition alongside day-to-day social functioning of people with Huntington’s disease
por: Fisher, Alexandra, et al.
Publicado: (2023)